Edwards Lifesciences
Corporation EW announced that the U.S. Court of
Appeals for the Federal Circuit today affirmed an April 2010 federal
jury decision that Medtronic MDT CoreValve LLC is willfully infringing
Edwards' U.S. Andersen transcatheter heart valve patent. The Appeals
Court also ordered the trial court to reconsider Edwards' request for
a permanent injunction that would prohibit the manufacture and sale
of the CoreValve System in the United States.
In addition, the Court affirmed the validity of this patent and the
federal jury's verdict awarding an initial payment of $74 million in
damages to Edwards, which covers infringement through early 2010.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in